APA (7th ed.) Citation

Pankert, M., Quilici, J., Loundou, A. D., Verdier, V., Lambert, M., Deharo, P., . . . Cuisset, T. (2014). Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting. American Journal of Cardiology, 113(1), 54. https://doi.org/10.1016/j.amjcard.2013.09.011

Chicago Style (17th ed.) Citation

Pankert, Mathieu, et al. "Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting." American Journal of Cardiology 113, no. 1 (2014): 54. https://doi.org/10.1016/j.amjcard.2013.09.011.

MLA (9th ed.) Citation

Pankert, Mathieu, et al. "Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting." American Journal of Cardiology, vol. 113, no. 1, 2014, p. 54, https://doi.org/10.1016/j.amjcard.2013.09.011.